Posts Tagged: west cancer center
Key Risk Factors Affecting Treatment Choice in Melanoma with Dr. G. Gary Tian
![](https://westcancercenter.org/wp-content/uploads/2023/07/G.-Gary-Tian.jpg)
Key Risk Factors Affecting Treatment Choice in Melanoma West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma. The group dives into the latest treatment options for metastatic melanoma,… Read more »
Genitourinary (Urinary) Cancers
Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal
![](https://westcancercenter.org/wp-content/uploads/2023/07/Screen-Shot-2023-07-17-at-9.40.14-AM.png)
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Download Our Mobile App
Meet Judy: Esophageal Cancer Survivor
![](https://westcancercenter.org/wp-content/uploads/2023/07/West-Cancer-Center.png)
Meet Judy: Esophageal Cancer Survivor Judy came to our West family after she and her husband moved from Florida to Memphis post-retirement. While in Florida, Judy was at high risk for developing esophageal cancer and received frequent screenings to ensure early detection. She was ultimately diagnosed with Stage IV esophageal cancer and would have… Read more »
Updates in GI Cancers with Dr. Axel Grothey
![](https://westcancercenter.org/wp-content/uploads/2023/07/Dr.-Axel-Grothey.png)
Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »
Cancer Updates: Free Dinner Series for Regional Providers
![](https://westcancercenter.org/wp-content/uploads/2023/06/Native-Article-Photo.jpg)
CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »
100% Response Rate in Skin Cancer Trial
![](https://westcancercenter.org/wp-content/uploads/2023/06/West-Cancer-Center.png)
Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »
Dr. Noam VanderWalde on Geriatric Oncology
![](https://westcancercenter.org/wp-content/uploads/2023/06/Noam-VanderWalde.jpg)
Geriatric Oncology is a strong field of interest for our Radiation Oncologist and Co-Director of Clinical Research, Dr. Noam VanderWalde. In this podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan (Johns Hopkins Medicine) and Dr Ben Movsas (Henry Ford Cancer Institute – Detroit). Click here to listen!